Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

Practice Exam

CPC Practice Exam and Study Guide Package

Practice Exam

What makes a good CPC Practice Exam? Questions and Answers with Full Rationale

CPC Exam Review Video

Laureen shows you her proprietary “Bubbling and Highlighting Technique”

Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page

Practice Exam

2018 CPC Practice Exam Answer Key 150 Questions With Full Rationale (HCPCS, ICD-9-CM, ICD-10, CPT Codes) Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

Respiratory Therapist Charges

In the near future we will be adding respiratory therapy services to our inpt/out patient hospital. I just met with out new respiratory therapist and they are stating the below services are able to be billed separately from the facility charge. I am new to facility coding (all experience is pro-fee coding) and all the information I am seeing is showing these service being included in the facility charge… any information would be greatly appreciated!!

Cough Assist Therapy; Initial
Cough Assist Therapy; Subsequent
Heated High Flow (HHF) (each hour)
Tracheostomy Teaching
Transcutaneous CO2 Monitoring; Initial
Transcutaneous CO2 Monitoring; Subsequent
Transport- Vent Pt (each 15 mins)

Thank you!

Medical Billing and Coding Forum

Integumentary or Respiratory – ENT

I’m new-ish to coding and I can generally figure things out, but this one is making me crazy. I’m coding for the ASC where the surgery was done, and it was originally sent to us as dx L89.9 and cpt 11440, but the outside coding company that we use occasionally came back with dx L08.9 & L90.5 and cpt 30124. Here is the op report info. I appreciate any help you can give me…

PREOPERATIVE DIAGNOSIS: DRAINING LESION NASAL DORSUM.

POSTOPERATIVE DIAGNOSIS: DRAINING LESION NASAL DORSUM, PROBABLE DERMOID CYST.

TITLE OF OPERATION: EXCISION OF CYSTIC TRACT AND CYST INVOLVING THE SUBCUTANEOUS ASPECTS OF THE NASAL DORSUM.

DESCRIPTION OF PROCEDURE: The patient was taken to the operating room and placed in the supine position on the operating table. After a satisfactory level of general anesthesia had been achieved, the patient was prepped and draped in the routine fashion for external nasal surgery. The area surrounding the lesion in question was then infiltrated with approximately 0.5 mL of 1% Xylocaine and 1:100,000 dilution of epinephrine to enhance perioperative hemostasis, as well as provide postoperative analgesia. After the patient had been prepped and draped then, a lacrimal probe was inserted into the dimple over the nasal dorsum and followed to a blind end within the subcutaneous tissues of the nose toward the nasal glabella. An elliptical incision was then made around the dimple itself and the soft tissue dissected around the lacrimal probe. This was carried down to the level of the nasal bones, where a larger cystic structure was encountered and opened. This was removed sharply from the nasal bones utilizing iris scissors. After what was felt to be a complete excision of the cystic lesion then the base of the wound was thoroughly cauterized using a needle tip Bovie. The wound was then irrigated with saline solution and closed in the following fashion: Subcutaneous tissue were approximated utilizing 5-0 chromic catgut suture. The skin was closed utilizing interrupted vertical mattress sutures of 5-0 nylon. Steri-Strips were then placed over the wound and the procedure terminated. Specimen was sent for permanent histological identification. The patient was then allowed to awaken from his anesthesia, was extubated on the operating table and taken to the PACU where he arrived in satisfactory condition maintaining his own protective reflexes. The blood loss during this procedure was no more than 10 mL with replacement with crystalloid fluid only. There were no drains and no intraoperative complications. It should be mentioned that the anesthesia was delivered LMA.
===============

The pathoology report reads: Nasal lesion with tract, removal: Minimal non-specific chronic inflammation and fibrosis.
– Reactive skin with underlying sebaceous units and skeletal muscle.

Please help. Thank you!

Medical Billing and Coding Forum

Integumentary or Respiratory?

I’m new-ish to coding and I can generally figure things out, but this one is making me crazy. I’m coding for the ASC where the surgery was done, and it was originally sent to us as dx L89.9 and cpt 11440, but the outside coding company that we use occasionally came back with dx L08.9 & L90.5 and cpt 30124. Here is the op report info. I appreciate any help you can give me…

PREOPERATIVE DIAGNOSIS: DRAINING LESION NASAL DORSUM.

POSTOPERATIVE DIAGNOSIS: DRAINING LESION NASAL DORSUM, PROBABLE DERMOID CYST.

TITLE OF OPERATION: EXCISION OF CYSTIC TRACT AND CYST INVOLVING THE SUBCUTANEOUS ASPECTS OF THE NASAL DORSUM.

DESCRIPTION OF PROCEDURE: The patient was taken to the operating room and placed in the supine position on the operating table. After a satisfactory level of general anesthesia had been achieved, the patient was prepped and draped in the routine fashion for external nasal surgery. The area surrounding the lesion in question was then infiltrated with approximately 0.5 mL of 1% Xylocaine and 1:100,000 dilution of epinephrine to enhance perioperative hemostasis, as well as provide postoperative analgesia. After the patient had been prepped and draped then, a lacrimal probe was inserted into the dimple over the nasal dorsum and followed to a blind end within the subcutaneous tissues of the nose toward the nasal glabella. An elliptical incision was then made around the dimple itself and the soft tissue dissected around the lacrimal probe. This was carried down to the level of the nasal bones, where a larger cystic structure was encountered and opened. This was removed sharply from the nasal bones utilizing iris scissors. After what was felt to be a complete excision of the cystic lesion then the base of the wound was thoroughly cauterized using a needle tip Bovie. The wound was then irrigated with saline solution and closed in the following fashion: Subcutaneous tissue were approximated utilizing 5-0 chromic catgut suture. The skin was closed utilizing interrupted vertical mattress sutures of 5-0 nylon. Steri-Strips were then placed over the wound and the procedure terminated. Specimen was sent for permanent histological identification. The patient was then allowed to awaken from his anesthesia, was extubated on the operating table and taken to the PACU where he arrived in satisfactory condition maintaining his own protective reflexes. The blood loss during this procedure was no more than 10 mL with replacement with crystalloid fluid only. There were no drains and no intraoperative complications. It should be mentioned that the anesthesia was delivered LMA.
===============

The pathoology report reads: Nasal lesion with tract, removal: Minimal non-specific chronic inflammation and fibrosis.
– Reactive skin with underlying sebaceous units and skeletal muscle.

Please help. Thank you!

Medical Billing and Coding Forum

Respiratory Failure with hypoxemia

So I keep getting denials from Inpatient claims where they say that the diagnosis code is J96.01-Resp Failure with hypoxia, but when I look in the discharge summary I only see hypoxemia.

So since hypoxia (deficiency in the amount of oxygen reaching to the tissue) and hypoxemia (abnormal low concentration of oxygen in blood) are 2 totally separate meanings does that mean that I can’t use J96.001; but instead I need to use J96.00 since they are not stating hypoxia or hypercapnia?

Medical Billing and Coding Forum

Postoperative respiratory failure’s introduction into the CMS value-based reimbursement model

Postoperative respiratory failure’s introduction into the CMS value-based reimbursement model

By Robert Stein, MD, CCDS, and Shannon Newell, RHIA, CCS, AHIMA-approved ICD-10-CM/PCS trainer

The accurate capture of acute respiratory failure has been a long-standing challenge for CDI programs. The accurate reporting of this condition as a post-procedural event can be even more difficult.

The importance of data quality for post-procedural acute respiratory failure will impact quality outcomes linked to reimbursement under the Hospital-Acquired Condition Reduction Program (HACRP), as well as the Hospital Value-Based Purchasing Program (HVBP), if language in the fiscal year (FY) 2017 IPPS proposed rule is finalized.

In this article we’ll provide insights into how clinical documentation and reported codes may impact payments, and guidance on some common CDI challenges to strengthen data quality.

 

Performance may impact reimbursement in FY 2018

A quality measure named Patient Safety Indicator (PSI) 11 has existed since 1998, when it was developed by the Agency for Health Care Research and Quality (AHRQ). The measure has been adopted for use by CMS and other comparative databases, such as the University HealthSystem Consortium and Healthgrades, to compare performance across hospitals.

If the proposed rule is finalized as written, how well your hospital performs on this measure will begin to impact hospital reimbursement under the two hospital pay-for-performance programs noted above. Reimbursement impact will begin in:

  • FY 2018 for the HACRP
  • FY 2019 for the HVBP

 

Performance for this measure will be assessed and scored, and the score will then be rolled into a weighted patient safety composite measure. Performance for the overall composite measure will then determine reimbursement impact. The name of this composite measure is the Patient Safety and Adverse Events Composite, previously known as the PSI 90 composite measure.

The Patient Safety and Adverse Events Composite measure was reviewed in last month’s column. What is important to note for PSI 11 is that performance for this measure will impact approximately 22% of the composite weight:

Data quality and PSI 11 performance

PSI 11 performance is determined by the diagnosis (ICD-10-CM) codes we submit on claims. This is a risk-adjusted measure evaluated using an observed over an expected ratio.

Discharges included in the measure:

  • All elective surgical discharges treated at the hospital are evaluated for comorbidities which impact the complexity of the patient mix and the associated expected rate of postoperative respiratory failure events

Identification of postoperative respiratory events:

  • Any discharge included in the measure which has one of the following ICD-10-CM codes on the claim triggers a reportable actual?or observed? postoperative respiratory failure event:

 

Additional details for key measure drivers can be found on review of PSI 11 specifications located on the AHRQ website at www.qualityindicators.ahrq.gov/Modules/psi_resources.aspx.

 

PSI 11 CDI vulnerabilities

In our review of thousands of medical records for hospitals across the country, we see common challenges which impact PSI 11 data quality. We discuss a few of the common questions we encounter below to assist your internal data quality efforts.

 

How do I recognize acute respiratory failure?

  • Acute respiratory failure is at the end of a continuum initiated by respiratory dysfunction resulting in abnormalities of oxygenation and/or carbon dioxide elimination
  • Acute on chronic respiratory failure is an exacerbation or decompensation of chronic respiratory failure

Clinical criteria to identify if not documented and/or to validate a documented diagnosis include:

  • The use of supplemental oxygen or non-invasive/invasive mechanical ventilation
  • Signs and symptoms indicative of increased work of breathing (e.g., dyspnea, tachypnea [respiratory rate greater than 28], respiratory distress, labored breathing, use of accessory muscles)
  • Impaired gas exchange, which may be identified by the following clinical indicators:

What is the definition of "prolonged" postoperative mechanical ventilation?

  • A code for mechanical ventilation (and intubation) should not be assigned postoperatively for mechanical ventilation when it is considered a normal part of surgery.
  • Prolonged mechanical ventilation should be reported for an extended period postoperatively. A general rule of thumb for extended is 48 hours with the start time as the time of intubation for the procedure. Provider documentation should support what appears to be an extended time, but is in fact unexpected given the procedure and/or patient complexity.

 

If the patient is extubated postoperatively, but continues to be treated with supplemental oxygen, when is a query for acute respiratory failure appropriate?

  • To determine if this represents acute respiratory failure the values for impaired oxygen exchange can be utilized, along with the amount of oxygen being administered to the patient.
  • The P/F ratio can be a helpful tool to identify respiratory failure criteria above for a patient receiving supplemental oxygen:
  • If an ABG test is not available, an estimated P/F ratio can be calculated:
  • An illustration of the calculation follows:
  • The P/F ratio is a useful tool to validate the presence of acute hypoxemic respiratory failure when patients are receiving supplemental oxygen.

 

When respiratory failure exists in a post-procedural patient, how do I determine if this is, and/or is not, related to the procedure?

  • Physician education to promote clear documentation which relates the respiratory failure to an underlying condition (e.g., COPD) and/or to a procedure, and/or to the anesthesia, is essential.
  • When such documentation is not clear, a documentation query or clarification is required.

 

In addition to the above, other record review findings which negatively impact PSI 11 data quality include:

  • Accurate reporting of mechanical ventilation duration:
  • Accurate selection of post-procedural respiratory failure as the principal diagnosis:

 

Summary

Value-based care will increasingly utilize claims-based measures to assess quality and cost outcomes linked to payment. To strengthen organizational performance for PSI 11, the following steps are suggested:

  • Establish synergy between the CDI program and quality department to support:
  • Promote point-of-care capture of risk-adjustment variables pertinent to PSI 11 performance:
  • Actively engage your CDI physician advisor with medical staff education and CDI record reviews to facilitate and promote accurate capture of documentation relevant to accurate cohort identification and risk adjustment

 

Editor’s note

Stein is associate director of the MS-DRG Assurance program for Enjoin, providing clinical insight and education as part of the pre-bill review process. He earned his CCDS credential in June 2013 and completed AHIMA’s ICD-10-CM/PCS coder workforce training in August 2013. Newell is the director of CDI quality initiatives for Enjoin. Her team provides health systems with physician-led education and infrastructure design to sustainably address documentation and coding challenges essential to optimal performance under value-based payments across the continuum. She has extensive operational and consulting expertise in coding and clinical documentation improvement, performance improvement, case management, and health information management. You can reach Newell at (704) 931-8537 or [email protected]. Opinions expressed are that of the authors and do not represent HCPro or ACDIS.

HCPro.com – HIM Briefings

Respiratory therapist billing for intubation

I often code for In-patient services. Recently I came across a situation where a Respiratory Therapist (Hospital employee) performed an Intubation and the physician is trying to bill for that Intubation. When I talked to the MD he argued that he gave the order and was in the room the entire time. I do not feel that the MD should bill since he did not actually perform the service. I would appreciate input from others that may have encountered this situation and if I am correct in my thoughts, what can I use to support them.
Just an additional note: I believe that in a Teaching Facility the MD’s often bill when they are training residents, but we are not a Teaching Facility.

Medical Billing and Coding Forum

Postoperative respiratory failure’s introduction into the CMS value-based reimbursement model

Postoperative respiratory failure’s introduction into the CMS value-based reimbursement model

By Robert Stein, MD, CCDS, and Shannon Newell, RHIA, CCS, AHIMA-approved ICD-10-CM/PCS trainer

The accurate capture of acute respiratory failure has been a long-standing challenge for CDI programs. The accurate reporting of this condition as a post-procedural event can be even more difficult.

The importance of data quality for post-procedural acute respiratory failure will impact quality outcomes linked to reimbursement under the Hospital-Acquired Condition Reduction Program (HACRP), as well as the Hospital Value-Based Purchasing Program (HVBP), if language in the fiscal year (FY) 2017 IPPS proposed rule is finalized.

In this article we’ll provide insights into how clinical documentation and reported codes may impact payments, and guidance on some common CDI challenges to strengthen data quality.

 

Performance may impact reimbursement in FY 2018

A quality measure named Patient Safety Indicator (PSI) 11 has existed since 1998, when it was developed by the Agency for Health Care Research and Quality (AHRQ). The measure has been adopted for use by CMS and other comparative databases, such as the University HealthSystem Consortium and Healthgrades, to compare performance across hospitals.

If the proposed rule is finalized as written, how well your hospital performs on this measure will begin to impact hospital reimbursement under the two hospital pay-for-performance programs noted above. Reimbursement impact will begin in:

  • FY 2018 for the HACRP
  • FY 2019 for the HVBP

 

Performance for this measure will be assessed and scored, and the score will then be rolled into a weighted patient safety composite measure. Performance for the overall composite measure will then determine reimbursement impact. The name of this composite measure is the Patient Safety and Adverse Events Composite, previously known as the PSI 90 composite measure.

The Patient Safety and Adverse Events Composite measure was reviewed in last month’s column. What is important to note for PSI 11 is that performance for this measure will impact approximately 22% of the composite weight:

 

Data quality and PSI 11 performance

PSI 11 performance is determined by the diagnosis (ICD-10-CM) codes we submit on claims. This is a risk-adjusted measure evaluated using an observed over an expected ratio.

Discharges included in the measure:

  • All elective surgical discharges treated at the hospital are evaluated for comorbidities which impact the complexity of the patient mix and the associated expected rate of postoperative respiratory failure events

Identification of postoperative respiratory events:

  • Any discharge included in the measure which has one of the following ICD-10-CM codes on the claim triggers a reportable actual?or observed? postoperative respiratory failure event:

 

Additional details for key measure drivers can be found on review of PSI 11 specifications located on the AHRQ website at www.qualityindicators.ahrq.gov/Modules/psi_resources.aspx.

 

PSI 11 CDI vulnerabilities

In our review of thousands of medical records for hospitals across the country, we see common challenges which impact PSI 11 data quality. We discuss a few of the common questions we encounter below to assist your internal data quality efforts.

 

How do I recognize acute respiratory failure?

  • Acute respiratory failure is at the end of a continuum initiated by respiratory dysfunction resulting in abnormalities of oxygenation and/or carbon dioxide elimination
  • Acute on chronic respiratory failure is an exacerbation or decompensation of chronic respiratory failure

Clinical criteria to identify if not documented and/or to validate a documented diagnosis include:

  • The use of supplemental oxygen or non-invasive/invasive mechanical ventilation
  • Signs and symptoms indicative of increased work of breathing (e.g., dyspnea, tachypnea [respiratory rate greater than 28], respiratory distress, labored breathing, use of accessory muscles)
  • Impaired gas exchange, which may be identified by the following clinical indicators:

What is the definition of "prolonged" postoperative mechanical ventilation?

  • A code for mechanical ventilation (and intubation) should not be assigned postoperatively for mechanical ventilation when it is considered a normal part of surgery.
  • Prolonged mechanical ventilation should be reported for an extended period postoperatively. A general rule of thumb for extended is 48 hours with the start time as the time of intubation for the procedure. Provider documentation should support what appears to be an extended time, but is in fact unexpected given the procedure and/or patient complexity.

 

If the patient is extubated postoperatively, but continues to be treated with supplemental oxygen, when is a query for acute respiratory failure appropriate?

  • To determine if this represents acute respiratory failure the values for impaired oxygen exchange can be utilized, along with the amount of oxygen being administered to the patient.
  • The P/F ratio can be a helpful tool to identify respiratory failure criteria above for a patient receiving supplemental oxygen:
  • If an ABG test is not available, an estimated P/F ratio can be calculated:
  • An illustration of the calculation follows:
  • The P/F ratio is a useful tool to validate the presence of acute hypoxemic respiratory failure when patients are receiving supplemental oxygen.

 

When respiratory failure exists in a post-procedural patient, how do I determine if this is, and/or is not, related to the procedure?

  • Physician education to promote clear documentation which relates the respiratory failure to an underlying condition (e.g., COPD) and/or to a procedure, and/or to the anesthesia, is essential.
  • When such documentation is not clear, a documentation query or clarification is required.

 

In addition to the above, other record review findings which negatively impact PSI 11 data quality include:

  • Accurate reporting of mechanical ventilation duration:
  • Accurate selection of post-procedural respiratory failure as the principal diagnosis:

 

Summary

Value-based care will increasingly utilize claims-based measures to assess quality and cost outcomes linked to payment. To strengthen organizational performance for PSI 11, the following steps are suggested:

  • Establish synergy between the CDI program and quality department to support:
  • Promote point-of-care capture of risk-adjustment variables pertinent to PSI 11 performance:
  • Actively engage your CDI physician advisor with medical staff education and CDI record reviews to facilitate and promote accurate capture of documentation relevant to accurate cohort identification and risk adjustment

 

Editor’s note: Stein is associate director of the MS-DRG Assurance program for Enjoin, providing clinical insight and education as part of the pre-bill review process. He earned his CCDS credential in June 2013 and completed AHIMA’s ICD-10-CM/PCS coder workforce training in August 2013. Newell is the director of CDI quality initiatives for Enjoin. Her team provides health systems with physician-led education and infrastructure design to sustainably address documentation and coding challenges essential to optimal performance under value-based payments across the continuum. She has extensive operational and consulting expertise in coding and clinical documentation improvement, performance improvement, case management, and health information management. You can reach Newell at (704) 931-8537 or [email protected]. Opinions expressed are that of the authors and do not represent HCPro or ACDIS.

HCPro.com – Briefings on Coding Compliance Strategies